Looks like Seeking Alpha is going to bring down another name Thursday. Raptor Pharmaceuticals ... sell off in the stock today but over the past 3 months, its still up more than 70 percent. [stock-tools exchange="NASDAQ" symbol="RPTP" …
In a bid to widen its portfolio of rare disease treatments, Raptor Pharmaceutical (NASDAQ: RPTP) has opened its wallet ... 34.2 million of the closing consideration payable in Raptor common stock at Raptor's election plus contingent …
Raptor Pharmaceuticals (RPTP) – A corporation that researches existing drugs to improve them through specialized drug targeting methods was up over 20% today after Lazard rated them a new “buy” and slapped a $16 price target on the …
Horizon Pharma PLC HZNP, -0.23% announced Monday a deal to buy Raptor Pharmaceutical Corp. rptp in cash deal valued at about $800 ... said Horizon Chief Executive Timothy Walbert. Raptor's stock, which is still inactive in …
Horizon, Saskatchewan
Horizon Pharma plc (HZNP) said that it agreed to acquire all of the issued and outstanding shares of Raptor Pharmaceutical Corp. (RPTP) common stock for $9.00 per share in cash, for an implied fully diluted equity value of …
com/ products/ aptag/ ; you may also be able to obtain vectors from research groups directly). A stock of culture supernatant containing RPTP ectodomain-PLAP fusion protein (or Fc fusion protein ). 3. Nitroblue tetrazolium (NBT)/5 …
They now have a USD 15.5 price target on the stock. Raptor Pharmaceutical Corp. has a 50 day moving average of 8.81 and a 200 day moving average of 6.51. It has a 52-week low of 2.94 and a 52-week high of 9.05. The share price of the …
Raptor Pharmaceutical Corp. (RPTP) was among the biggest gainers on the Russell 2000 for Wednesday August 17 as the stock popped 5.67% to $6.90, representing a gain of $0.37 per share. Some 5.43 million shares traded hands on …
Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) reported its last earnings on Nov 03 AMC (BMO ... Corp. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.15/share. …
according to RPTP‘s most recent press release. Peaker believes that the market will indeed pay high prices for the drug, and he expects the key driver of the stock to be the pricing announcement that is expected in several weeks. “The …